/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) invites to a conference call on the supporting clinical data from the completed dose escalation section of.
/PRNewswire/ April – June Financial summary for the quarter Net turnover amounted to SEK 0.9 (4.0) million. The loss before interest, tax, depreciation and.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) announced today that Medivir AB ("Medivir" or "the Company") together with the originators of remetinostat,.